U.S. Global Investors (USGI)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-3,700
Closed -$269K 347
2015
Q1
$269K Hold
3,700
0.08% 192
2014
Q4
$255K Buy
+3,700
New +$250K 0.07% 181
2014
Q2
Sell
-4,500
Closed -$265K 340
2014
Q1
$265K Hold
4,500
0.04% 214
2013
Q4
$230K Buy
+4,500
New +$225K 0.04% 235

Other funds holding LLY

U.S. Global Investors (USGI)'s LLY Position: Q2 2015 in Review

U.S. Global Investors (USGI) sold out of Eli Lilly (LLY) in Q2 2015, closing a stake of 3,700 shares — an estimated $269K sold.

U.S. Global Investors (USGI) first reported a position in LLY in Q4 2013 and held it in 4 quarters. The position peaked at $269K in Q1 2015. 1,138 funds tracked by Wall St. Rank hold LLY as of Q2 2015.

  • U.S. Global Investors (USGI) reported no remaining Eli Lilly position as of Q2 2015 after selling out during the quarter.
  • U.S. Global Investors (USGI) sold 3,700 Eli Lilly shares in Q2 2015, an estimated $269K.
  • U.S. Global Investors (USGI) first reported a position in Eli Lilly in Q4 2013 and held it in 4 quarters.
  • U.S. Global Investors (USGI)'s Eli Lilly position peaked at $269K in Q1 2015.
  • 1,138 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2015.

Based on U.S. Global Investors (USGI)'s 13F filing for Q2 2015, filed 14 Aug 2015.